Test Price
2,800 AED✅ Home Collection Available
TPM3 Gene Nemaline Myopathy Type 1 Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
- Diagnostic Accuracy: >99.9% sensitivity for pathogenic variants in the TPM3 gene via full-gene NGS and CNV analysis.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM – 11 PM.
- Medical Guidance: Post-test telephone consultation with a Consultant Medical Geneticist for result interpretation.
- Insurance Verification: Direct coverage check via WhatsApp +971 54 548 8731.
- Turnaround Time: 3–4 weeks from sample reception.
- Price: 2800 AED (includes pre-test genetic counselling and report).
Test Overview & Methodology
The TPM3 gene Nemaline Myopathy Type 1 genetic test employs next-generation sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations in the TPM3 gene. This test provides a definitive molecular diagnosis for Nemaline Myopathy Type 1 (NEM1), a congenital neuromuscular disorder characterized by muscle weakness and respiratory complications. A mandatory pre-test genetic counselling session, including a pedigree chart, is required before sample collection.
| Feature | Our Test (DHA-Accredited) | Closest Alternative |
|---|---|---|
| Methodology | Full gene NGS + CNV analysis | Targeted mutation panel or single-site testing |
| Diagnostic Yield | >99.9% sensitivity for all variant types | Limited to known hotspots, may miss novel variants |
| Turnaround Time | 3–4 Weeks | 10–14 Days |
| Pre-Test Requirement | Mandatory genetic counselling & pedigree chart | Often minimal or no counselling |
Physician Insight & Safety Protocols
“Confirmation of a TPM3 pathogenic variant provides a clear genetic diagnosis, guides prognosis, and enables informed family planning. However, a negative result does not rule out other genetic causes; all findings must be correlated with a detailed neuromuscular examination and interpreted within the context of the family history. Always maintain prescribed therapies unless explicitly adjusted by your neurologist.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Pre-Test Genetic Counselling
Required Before Sample Collection:
- Informed consent document signed by patient (or legal guardian if minor).
- Completion of a pre-test genetic counselling session (included in the test cost).
- Submission of a three-generation pedigree chart to assist variant interpretation.
- Do not discontinue any prescribed medication without consulting your physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Unable to provide informed consent; medically unstable for venipuncture; missing mandatory pre-test genetic counselling.
- Minors: Legal guardian consent strictly required under UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: If you experience sudden respiratory distress, severe muscle weakness causing inability to walk or swallow, seek immediate emergency care. This test is not intended for acute diagnosis.
Patient FAQ & Clinical Guidance
1. What is the TPM3 gene test used for?
This DNA test analyzes the TPM3 gene to detect mutations causing nemaline myopathy type 1, a congenital muscle disorder. It confirms the molecular diagnosis, guides prognosis, and facilitates family counselling.
2. How is the sample collected and what are the requirements?
A blood sample (whole blood, extracted DNA, or FTA card) is collected via our VIP mobile phlebotomy service at your home between 8 AM and 11 PM. A pre-test genetic counselling session is mandatory before collection.
3. How long do results take and what do they mean?
Results are typically available within 3 to 4 weeks. A positive result confirms a genetic diagnosis of nemaline myopathy type 1. A negative result does not exclude all genetic causes; your geneticist will discuss implications during a post-test consultation.
4. What happens if my insurance does not cover the test?
We offer a direct insurance verification service via WhatsApp (+971 54 548 8731). If coverage is declined, the test is available at a self-pay price of 2800 AED, which includes all counselling and logistics.
UAE Regulatory & Data Privacy Adherence
Compliance Framework: This test is conducted in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability (patient consent and safety standards).
- DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
All genetic data are encrypted and stored within secure, access-controlled servers. No raw data is shared with third parties without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | TPM3 Gene Sequencing (Nemaline Myopathy Type 1) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card (peripheral blood). VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available. |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis |
| ICD-10-CM Code | G71.2 (Congenital myopathies) |
| LOINC Code | 94400-5 (TPM3 gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians